These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3310165)

  • 1. [Inhibition of prostaglandin synthesis suppresses the renal functional reserve in patients with lupus nephropathy].
    Herrera-Acosta J; Reyes PA; López Manay G; Padilla L; Cerdas Calderón M; Ruiz A; Pérez Grovas H
    Rev Invest Clin; 1987; 39(2):107-14. PubMed ID: 3310165
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
    Vriesendorp R; de Zeeuw D; de Jong PE; Donker AJ; Pratt JJ; van der Hem GK
    Clin Nephrol; 1986 Feb; 25(2):105-10. PubMed ID: 3516475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous aspirin on prostaglandin synthesis and kidney function in intensive care patients.
    Bock HA; Frölich JC; Ritz R; Brunner FP
    Nephrol Dial Transplant; 1986; 1(3):164-9. PubMed ID: 3110670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of inhibition of prostaglandin synthesis on plasma renin activity during hemodialysis].
    Chmielewska J; Myśliwiec M; Giedrojć Z
    Pol Tyg Lek; 1983 Sep; 38(39):1203-5. PubMed ID: 6371733
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal prostaglandins in systemic lupus erythematosus.
    Kimberly RP
    Lancet; 1978 Sep; 2(8089):553-5. PubMed ID: 79920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active and acid-activable inactive renin during inhibition by indomethacin of prostaglandin synthesis in sodium-replete man.
    Lijnen P; Staessen J; Fagard R; Groeseneken D; M'Buyamba-Kabangu JR; Grauwels R; Amery A
    Eur J Clin Invest; 1985 Jun; 15(3):141-5. PubMed ID: 3926508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prostaglandin inhibition on demeclocycline administration in conscious rats.
    Serros ER; Lowe AG; Kirschenbaum MA
    Prostaglandins Med; 1980 Sep; 5(3):175-82. PubMed ID: 6774355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
    Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
    J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of indomethacin on the plasma renin activity in patients with arterial hypertension].
    Rossi GC; Mattioli M; Corgnati A; Lechi C; Pedrolli E; Covi G; Lechi A
    G Clin Med; 1976; 57(9-10):298-310. PubMed ID: 1027654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Derivatives of arachidonic acid. II. Medical perspectives].
    Anker R; Quezada A
    Bol Med Hosp Infant Mex; 1986 May; 43(5):316-22. PubMed ID: 3524602
    [No Abstract]   [Full Text] [Related]  

  • 13. Sweet's syndrome and systemic lupus erythematosus.
    Gollol-Raju N; Bravin M; Crittenden D
    Lupus; 2009 Apr; 18(4):377-8. PubMed ID: 19276309
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function.
    Kallenberg CG; Schweitzer C; de Jong PE; Donker AJ; van der Hem GK
    Clin Nephrol; 1984 Nov; 22(5):223-9. PubMed ID: 6518673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of indomethacin in patients with systemic lupus erythematosus.
    ter Borg EJ; de Jong PE; Meijer S; Kallenberg CG
    Nephron; 1989; 53(3):238-43. PubMed ID: 2677808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin on active and inactive renin in sodium-replete men at rest and during exercise.
    Lijnen P; Groeseneken D; Fagard R; Staessen J; Amery A
    J Lab Clin Med; 1984 May; 103(5):677-83. PubMed ID: 6425442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study of renal hemodynamics in patients with lupus nephritis].
    Nakano M; Hasegawa H; Watanabe T; Kuroda T; Ito S; Saeki T; Ueno M; Ozawa T; Kikuchi M; Sato T
    Ryumachi; 1994 Aug; 34(4):725-32. PubMed ID: 7974023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of drugs that inhibit prostaglandin synthesis.
    Dunn MJ; Zambraski EJ
    Kidney Int; 1980 Nov; 18(5):609-22. PubMed ID: 7007713
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandins E1 and E2 antagonize indomethacin-induced decrease in survival rate of haemorrhagically shocked rats.
    Perbeck L; Hedqvist P
    Acta Chir Scand Suppl; 1980; 500():91-4. PubMed ID: 6939202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.